During rehabilitation, a patient with spinal cord injury begins to ambulate with long leg braces. Which level of injury does the nurse associate with this degree of recovery?

A. Estrogen and progesterone. These hormones regulate the reproductive system and do not play a direct role in Parkinsonism. While some studies suggest estrogen may have a neuroprotective effect, an imbalance between estrogen and progesterone is not the primary defect in Parkinson’s disease.
B. An autosomal dominant genetic defect. Parkinson’s disease can have a genetic component, but idiopathic Parkinsonism occurs without a clear genetic cause. Most cases are sporadic and result from dopamine depletion, rather than an inherited genetic mutation.
C. Dopamine and acetylcholine. Parkinsonism results from a deficiency of dopamine in the basal ganglia, leading to an imbalance between dopamine (inhibitory) and acetylcholine (excitatory). This imbalance causes motor symptoms such as tremors, rigidity, and bradykinesia. Benztropine (Cogentin) is an anticholinergic medication that helps reduce acetylcholine activity, restoring balance and improving symptoms.
D. Atherosclerosis and lack of blood supply. While vascular issues can contribute to stroke-related movement disorders, idiopathic Parkinsonism is caused by neurodegeneration, not blood flow problems. Atherosclerosis is not the primary cause of the dopamine-acetylcholine imbalance seen in Parkinsonism.

A: "Sumatriptan." Sumatriptan is a selective serotonin receptor agonist (triptan) used for the acute treatment of migraines. It acts by stimulating serotonin (5-HT) receptors in the brain, specifically the 5-HT_1B and 5-HT_1D subtypes. This action causes vasoconstriction of dilated intracranial blood vessels and inhibits the release of pro-inflammatory neuropeptides, effectively reducing headache pain and associated symptoms such as nausea and photophobia. Sumatriptan can be administered via oral, subcutaneous, or nasal spray routes and is generally well-tolerated, with a rapid onset of action.
B: "Atorvastatin." Atorvastatin is a lipid-lowering agent belonging to the statin class, primarily used to decrease low-density lipoprotein (LDL) cholesterol levels and reduce the risk of cardiovascular events. It functions by inhibiting HMG-CoA reductase, an enzyme involved in cholesterol biosynthesis in the liver. Atorvastatin does not have a role in migraine treatment and is not indicated for this purpose.
C: "Metformin." Metformin is an oral hypoglycemic agent used in the management of type 2 diabetes. It works by decreasing hepatic glucose production and improving insulin sensitivity in peripheral tissues. Metformin is not indicated for migraine treatment and has no known effect on migraine pathophysiology.
D: "Lisinopril." Lisinopril is an angiotensin-converting enzyme (ACE) inhibitor used primarily for the management of hypertension and heart failure. It works by inhibiting the conversion of angiotensin I to angiotensin II, resulting in vasodilation and reduced blood pressure. While lisinopril may have some preventative effects for migraines in certain patients, it is not used for acute migraine treatment.